Clinical Trial Update: Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Lutathera (lutetium-177 dotatate) for recurrent or progressive high-grade central nervous system tumors, currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Ependymoma
• Central Nervous System Neoplasm
• Diffuse Intrinsic Pontine Glioma
• Embryonal Tumor
• High-grade Glioma
• Malignant Glioma
• Medulloblastoma
• Meningioma

Drugs mentioned

• LUTATHERA (Lutetium Lu-177 dotatate)

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: High Grade Glioma, Meningioma | Phase 1, Phase 2 | Status: RECRUITING